Joan Schwartz releases 'Divine Healing: Ancient Secrets of Our Ancestors'
New book bridges science and spirituality with the Integrated Healing Dynamics Method for self-guided mind-body-spirit healing
RIVERTON, Utah, June 11, 2025 /PRNewswire-PRWeb/ -- First-time author Joan Schwartz marks her entry into publishing with the release of "Divine Healing: Ancient Secrets of Our Ancestors" (published by Balboa Press). Blending ancient spiritual insight with contemporary scientific understanding, this book introduces the Integrated Healing Dynamics (IHD) Method — a holistic, accessible healing framework designed to awaken the innate power within every individual.
Rooted in a vision that first appeared to her in 1988, Schwartz says the inspiration for "Divine Healing" came through higher guidance. "I had a revelation and saw the book from beginning to end," she recalls. "Later, I was given direction to write a healing book so that if people couldn't get a session or help from me, they could heal themselves."
"Divine Healing: Ancient Secrets of Our Ancestors" is a complete healer's resource that empowers readers with the knowledge and techniques to realign their energy, awaken their body's natural healing systems, and cultivate peace, joy, and self-love. The IHD Method taught in the book is the culmination of a lifetime of spiritual dialogue and deep intuitive knowing. Through its simple, step-by-step exercises and guiding principles, readers are invited to remove the "mask" that blocks them from their true essence — and step into their divine right to healing.
"Healing is not just about the body; it is about the mind and spirit too," the author reminds. From relieving physical pain to addressing emotional wounds and spiritual imbalances, "Divine Healing: Ancient Secrets of Our Ancestors" offers a practical roadmap to transformation. To get a copy and learn more, visit https://www.balboapress.com/en/bookstore/bookdetails/847934-divine-healing.
"Divine Healing: Ancient Secrets of Our Ancestors" By Joan Schwartz Hardcover | 6 x 9in | 836 pages | ISBN 9798765255186 Softcover | 6 x 9in | 836 pages | ISBN 9798765255162 E-Book | 836 pages | ISBN 9798765255179 Available at Amazon and Barnes & Noble
About the Author Joan Schwartz is a seasoned hypnotherapist and integrative healer with decades of experience in energy work, clinical hypnotherapy, and alternative healing. Her journey began in childhood with a deep sensitivity to unseen energies and was shaped by transformative life events, including a pivotal car accident in 1965 and a near-fatal brain hemorrhage. With a Ph.D. in Alternative Healing, Clinical Hypnotherapy and Philosophy, Schwartz blends science and spirituality to empower others in unlocking their healing potential. She is passionate about helping individuals live peaceful, fulfilling lives through self-discovery and holistic healing practices.
Balboa Press, a division of Hay House, Inc. – a leading provider in publishing products that specialize in self-help and the mind, body, and spirit genres. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the self-publishing model. For more information, visit balboapress.com. To start publishing your book with Balboa Press, call 844-682-1282 today.
Media Contact
Marketing Services, BalboaPress, 844-682-1282, pressreleases@balboapress.com, https://www.balboapress.com/en/bookstore/bookdetails/847934-divine-healing
View original content to download multimedia:https://www.prweb.com/releases/joan-schwartz-releases-divine-healing-ancient-secrets-of-our-ancestors-302478348.html
SOURCE BalboaPress
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
Vytanutra Launches Sustained Release Vitamin C with Iron for Daily Immune Support
IRVINE, Calif., June 12, 2025 /PRNewswire/ -- Vytanutra proudly announces the release of its newest product, Vytanutra C, Ascorbic Acid a scientifically formulated supplement designed to deliver consistent immune and support Collagen Synthesis throughout the day. This advanced formula features Sustained-release Pellet technology, paired with Iron, and is made to meet the needs of modern wellness seekers. Each capsule delivers a steady supply of Vitamin C to help maintain healthy immune function, support collagen production, and provide ongoing protection against oxidative stress. Enhanced with Sustained release coating technology, the beadlets are designed for gradual release and optimal stability, helping preserve potency and ensure consistent absorption over time. Key Features: • Extended-Release Pellet System – The spherical pellet is designed to enlarge the absorption area in the GI tract and deliver Vitamin C steadily for 12 hours, helping maintain a stable plasma concentration in the blood. • Non-GMO, Vegan, and Gluten-Free – Clean and conscious formulation suitable for various dietary needs Each bottle contains 90 Pellet capsules, making it a convenient and reliable choice for individuals seeking daily immune system support with long-lasting effects. Now Available on AmazonVisit the Vytanutra Amazon Store and search "Vytanutra C" to explore the latest in immune support innovation. Stay strong. Stay resilient. Experience all-day wellness with Vytanutra Immune Support Vitamin C. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Contact:Sean TangAccount Manager396609@ View original content to download multimedia: SOURCE Vytanutra
Yahoo
an hour ago
- Yahoo
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting
LA JOLLA, Calif., June 12, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced an upcoming symposium entitled "Auxora for the Treatment of AKI" at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology meeting being held June 24-26 in Vicenza, Italy. Details for the oral presentations to be presented during the symposium are as follows: Presentation Title: Overview of Calcium Release-Activated Calcium (CRAC) ChannelsPresenter: Sudarshan Hebbar, M.D., Chief Medical Officer of CalciMedicaDate and Time: Tuesday, June 24, 1:45-2:00 p.m. CEST Presentation Title: The Role of IL-17 in the Pathophysiology of AKIPresenter: Javier Neyra, M.D., Associate Professor of Medicine and Associate Director of the Nephrology Research & Training Center at University of Alabama at BirminghamDate and Time: Tuesday, June 24, 2:00-2:20 p.m. CEST Presentation Title: KOURAGE (NCT06374797)Presenter: Lakhmir Chawla, M.D., Clinical Professor of Medicine at University of California San Diego, Chief Medical Officer at ExThera Medical, and Chair of the KOURAGE Steering CommitteeDate and Time: Tuesday, June 24, 2:20-2:35 p.m. CEST Webcasts of the presentations will be available following the sessions on the Medical Events & Presentations section of CalciMedica's IR website at About CalciMedicaCalciMedica is a clinical-stage biopharmaceutical company focused on developing novel CRAC channel inhibition therapies for inflammatory and immunologic diseases. CalciMedica's proprietary technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory and immunologic diseases for which there are currently no approved therapies. CalciMedica's lead product candidate Auxora™ has demonstrated positive and consistent clinical results in multiple completed efficacy clinical trials and been well-tolerated in over 350 critically ill patients dosed. CalciMedica has announced data for a Phase 2b trial (called CARPO – NCT04681066) in patients with acute pancreatitis (AP) and accompanying systemic inflammatory response syndrome (SIRS) and for a Phase 2 trial (called CARDEA – NCT04345614) in patients with COVID pneumonia. The Company is currently conducting a Phase 2 trial (called KOURAGE –NCT06374797) in patients with acute kidney injury (AKI) with associated acute hypoxemic respiratory failure (AHRF). For more information, please visit Contact InformationArgot Partnerscalcimedica@ 600-1902 View original content to download multimedia: SOURCE CalciMedica, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Renowned Gynaecologist Joins Manipal Hospital Gurugram to Strengthen Women's Health
GURUGRAM, India, June 12, 2025 /PRNewswire/ -- Manipal Hospital, one of the leading healthcare institutions in Gurugram, welcomes renowned surgeon Dr Amita Shah, Chairman & HOD, Obstetrics & Gynecology, Laparoscopy Endoscopy. Dr Shah has joined the expert team of Manipal Hospital Gurugram, to strengthen and enhance the medical expertise of healthcare delivery to the people of Gurugram. Through dedicated women's wellness and preventive health initiatives, she contributes to early detection and long-term health planning. Dr Amita Shah will further enhance Manipal Hospital's expertise with extensive knowledge and experience spanning more than 29 years in diagnosing and treating numerous complex gynaecological issues. She is an expert in procedures like 3D and Robotic-Assisted Laparoscopic Gynaecological Surgeries, Gynae Oncology – Screening & Management, Infertility & Reproductive Endocrinology and many more. Her focus is to provide preventive health, advanced management of gynaecological disorders, and fertility care through a dedicated specialty clinic that has cutting-edge technology to treat advanced gynaecological issues. She is an active member of the Indian Fertility Society (IFS) and the Indian Association of Gynae Endoscopists (IAGE). Her addition to the team strengthens the hospital's capabilities in providing comprehensive heart care. Dr Shah practices a 360-degree approach to women's health, providing care from conception through childbirth and postnatal vaccination, making Manipal Hospital a one-stop destination for maternity and reproductive care. She will play a key role in various Obstetrics and Gynecological programs such as Spandan, a parent support initiative aimed at easing the journey of parenthood through expert-led educational sessions and Manipal Sakhi, a comprehensive health card packed with exclusive patient benefits for women. Expressing his enthusiasm for joining the team, Navin Pascal, Hospital Director, Manipal Hospital, Gurugram, said, "We are delighted to have Dr Amita Shah in our team of medical experts. With a wealth of experience in women's healthcare, Dr. Shah brings with her a deep commitment to clinical excellence and patient-centered care. Her expertise across complex gynaecological procedures, high-risk obstetrics, and holistic reproductive health makes her a valuable addition to our multidisciplinary team. With her being a part of Manipal Hospital, we will be able to deliver advanced clinical management of gynaecological disorders, including minimally invasive and robotic surgeries for faster recovery and improved outcomes. At Manipal Hospital, we are dedicated to continuously enhancing the quality and scope of our healthcare services. Her joining marks a significant step in our ongoing efforts to elevate healthcare standards in Gurugram and assure our position as a trusted leader in women's health." About Manipal Hospitals As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out of hospital care. With the completion of acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 37 hospitals across 19 cities with 10,500+ beds, and a talented pool of 5,600+ doctors and an employee strength of over 18,600. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH, AAHRPP accredited and most of the hospitals in its network are NABL, ER, Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognised the most respected and patient recommended hospital in India through various consumer surveys Photo - - - View original content to download multimedia:
